The impact of tissue characterization for in-stent restenosis with optical coherence tomography during excimer laser coronary angioplasty

被引:0
作者
Sho Hashimoto
Akihiko Takahashi
Yukio Mizuguchi
Takeshi Yamada
Norimasa Taniguchi
Tetsuya Hata
Shunsuke Nakajima
机构
[1] Sakurakai Takahashi Hospital,Department of Cardiology
来源
Cardiovascular Intervention and Therapeutics | 2019年 / 34卷
关键词
Excimer laser coronary angioplasty; In-stent restenosis; Optical coherence tomography;
D O I
暂无
中图分类号
学科分类号
摘要
We aimed to evaluate the impact of tissue characterization for in-stent restenosis (ISR) with optical computed tomography (OCT) during excimer laser coronary angioplasty (ELCA) in the drug-eluting stent (DES) era. The effect of ELCA for ISR according to differences in tissue characteristics is unclear. Fifty-three ISR lesions (7 bare metal stents and 46 drug-eluting stents) were treated with an ELCA catheter. After ELCA, balloon dilatation with either the scoring or non-compliant balloons was conducted. The procedure was completed by applying a drug-coated balloon. Tissue characterization and lumen measurement with OCT were performed thrice: (1) before percutaneous coronary intervention (PCI), (2) after ELCA, and (3) and after the procedure. Lesions were categorized into the homogenous, layered, and mixed groups. Follow-up angiograms were conducted 6–12 months after PCI. No significant differences in minimal lumen area (MLA) were observed before PCI. A significant difference was observed in MLA after ELCA among the three groups (homogeneous group: 1.75 ± 0.84 mm2, layered group: 1.72 ± 0.45 mm2, mixed group: 2.24 ± 0.70 mm2, P = 0.048). Final MLA was larger in the mixed group than in the homogeneous group (P = 0.028). No significant difference was observed in binary restenosis in the follow-up angiogram (homogeneous group 55.5%, layered group 33.3%, mixed group 33.3%; P = 0.311) and the target lesion revascularization rate (homogeneous 30.0%, layered 23.8%, mixed 25.0%; P = 0.923). Tissue characterization by OCT may predict the efficacy of ELCA and balloon angioplasty for ISR during the acute phase.
引用
收藏
页码:171 / 177
页数:6
相关论文
共 21 条
  • [1] Kastrati A(2007)Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction Eur Heart J 28 2706-2713
  • [2] Dibra A(2007)Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials J Am Coll Cardiol 49 616-623
  • [3] Stolker JM(2012)Repeat revascularization after contemporary percutaneous coronary intervention: an evaluation of staged, target lesion, and other unplanned revascularization procedures during the first year Circ Cardiovasc Interv 5 772-782
  • [4] Mehran R(1997)Treatment of in-stent restenosis with excimer laser coronary angioplasty versus rotational atherectomy comparative mechanisms and results Circulation 96 2183-2189
  • [5] Radke PW(2003)Outcome after treatment of coronary in-stent restenosis: results from a systematic review using meta-analysis techniques Eur Heart J 24 266-273
  • [6] Kaiser A(2009)Optical coherence tomography patterns of stent restenosis Am Heart J 158 284-293
  • [7] Frost C(2014)Mechanisms of postintervention and nine-month luminal enlargement after treatment of drug-eluting in-stent restenosis with a drug-eluting balloon Am J Cardiol 113 1468-1473
  • [8] Sigwart U(2006)Comparison with conventional therapies of repeated sirolimus-eluting stent implantation for the treatment of drug-eluting coronary stent restenosis Am J Cardiol 98 1451-1454
  • [9] Gonzalo N(2013)Qualitative and quantitative assessment of stent restenosis by optical coherence tomography—comparison between drug-eluting and bare-metal stents Circ J 77 652-660
  • [10] Lee S-Y(2015)Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilata Eur Heart J Cardiovasc Imaging 16 1101-1111